Recurrent Low Grade Glioma Clinical Trials in Memphis, Tennessee
2 recruitingMemphis, Tennessee
Showing 1–2 of 2 trials
Recruiting
Phase 2
Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas
BRAF V600 MutationLow-grade GliomaLow Grade Glioma of Brain+1 more
University of California, San Francisco96 enrolled5 locationsNCT07110246
Recruiting
Phase 1Phase 2
SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma
Low-grade GliomaRecurrent Low Grade GliomaProgressive Low-Grade Glioma
St. Jude Children's Research Hospital132 enrolled1 locationNCT04923126